{"name":"Freenome","slug":"freenome","ticker":"PRIVATE","exchange":"Private","domain":"freenome.com","description":"Freenome is a private biotechnology company focused on developing AI-powered multi-omics diagnostics for cancer and other diseases. The company's flagship product is a liquid biopsy test for early cancer detection. Freenome has established partnerships with leading healthcare organizations and has received significant funding from top venture capital firms.","hq":"South San Francisco, CA","founded":0,"employees":"","ceo":"Mike Nolan","sector":"Diagnostics / AI Multiomics","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$2.5B (private, estimated)","metrics":{"revenue":25000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"deal","headline":"Freenome Raises $270M in Series C Funding","summary":"Freenome secured $270 million in Series C funding to accelerate the development of its AI-powered multi-omics diagnostics.","drugName":"","sentiment":"positive"},{"date":"2023-09-14","type":"deal","headline":"Freenome Partners with Merck to Develop AI-Powered Cancer Diagnostics","summary":"Freenome partnered with Merck to develop AI-powered cancer diagnostics using multi-omics data.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOaG5oYmUxOXdlRFRRQXMydEc0emVSWXhMUV9CSmJmMUdMUkVKSElaZjlOQmRVeXBOU1lia3huTl90d2wtS2lVSVpYb0Z2eWdoSG5Mb2hDbURrOUFiTFRjMmlvNnFaSGFRazZOekVvb1c0ck5sMnJLYWZ4dHhaMFVVYW9qWU5HTGNZU194S0wtaw?oc=5","date":"2024-05-29","type":"pipeline","source":"drugdiscoverytrends.com","summary":"100 of the best-funded private healthcare and biotech companies - drugdiscoverytrends.com","headline":"100 of the best-funded private healthcare and biotech companies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Grail","Foundation Medicine","Invitae"],"therapeuticFocus":["Oncology","Precision Medicine"],"financials":null,"yahoo":null}